Inhibition of Gln metabolism significantly reduces cFLIP levels, leading to the formation of the death-inducing signaling complex mediated by TRAIL
With obesity rates rising, the public health challenge is significant
It may be time to start managing the condition with medication
Antitransforming growth factor-beta therapy in fibrosis: recent progress and implications for systemic sclerosis
PMID: 28645937, PMCID: PMC5669155, DOI: 10.1161/jaha.116.005040
However, in contrast to anti-hyperlycemic agents such as metformin, pioglitazone and peroxisome proliferator-activated receptor gamma (PPAR) agonists, which were particularly well studied in this matter, very few clinical studies concerning the effects of GLP-1R targeting therapeutics on alleviation of depressive symptoms in humans have been carried out so far [118, 119]